The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial

Christina U. Lorentz, Erik I. Tucker, Norah G. Verbout, Joseph J. Shatzel, Sven R. Olson, Brandon D. Markway, Michael Wallisch, Martina Ralle, Monica T. Hinds, Owen J.T. McCarty, David Gailani, Jeffrey I. Weitz, András Gruber

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds